Medium

Step 1: The overall sentiment of the management's discussion is cautiously optimistic. While there have been disruptions due to COVID-19 impacting all segments of the business, there is gradual improvement in accessibility, with an anticipation of an acceleration of business momentum once the crisis subsides.

Step 2: Relevant numbers and figures provided involve revenue changes. In the third quarter of 2020, revenues increased slightly compared to the same period in 2019, but for the first nine months of 2020, there was a decrease in revenues. This fluctuation indicates some instability.

Step 3: The costs of revenue decreased for Research & Development Solutions and Contract Sales & Medical Solutions, but increased for Technology & Analytics Solutions. This change reflects a mixed performance across the different segments, with potential challenges in certain areas of the business.

Based on the mixed performance, cautious optimism, and the need for acceleration once the crisis subsides, the company is classified as having a medium risk of bankruptcy. The fluctuating revenues and the need for cost containment actions indicate potential financial strain.